NEWARK, DE | The self-administered biologics market was valued at USD 98.3 billion in 2025 and is estimated to reach USD 102.7 billion in 2026. Demand is projected to grow to USD 159.5 billion by 2036, reflecting a CAGR of 4.5% during the forecast period. This sustained expansion, with an absolute dollar growth of USD 56.8 billion over the decade, is anchored in the structural demand...